Literature DB >> 19696027

Endothelial and smooth muscle-derived neuropilin-like protein regulates platelet-derived growth factor signaling in human vascular smooth muscle cells by modulating receptor ubiquitination.

Xiaojia Guo1, Lei Nie, Leila Esmailzadeh, Jiasheng Zhang, Jeffrey R Bender, Mehran M Sadeghi.   

Abstract

Endothelial and smooth muscle cell-derived neuropilin-like protein (ESDN) is up-regulated in the neointima of remodeling arteries and modulates vascular smooth muscle cell (VSMC) growth. Platelet-derived growth factor (PDGF) is the prototypic growth factor for VSMCs and plays a key role in vascular remodeling. Here, we sought to further define ESDN function in primary human VSMCs. ESDN down-regulation by RNA interference significantly enhanced PDGF-induced VSMC DNA synthesis and migration. This was associated with increased ERK1/2, Src, and PDGF receptor (PDGFR)beta phosphorylation, without altering total PDGFRbeta expression levels. In binding assays, ESDN down-regulation significantly increased (125)I-PDGF maximum binding (B(max)) to PDGF receptors on VSMCs without altering the binding constant (K(d)), raising the possibility that ESDN regulates PDGFR processing. ESDN down-regulation significantly reduced ligand-induced PDGFRbeta ubiquitination. This was associated with a significant reduction in the expression level of c-Cbl, an E3 ubiquitin ligase that ubiquitinylates PDGFRbeta. Thus, ESDN modulates PDGF signaling in VSMCs via regulation of PDGFR surface levels. The ESDN effect is mediated, at least in part, through effects on PDGFRbeta ubiquitination. ESDN may serve as a target for regulating PDGFRbeta signaling in VSMCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696027      PMCID: PMC2785569          DOI: 10.1074/jbc.M109.049684

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  ESDN, a novel neuropilin-like membrane protein cloned from vascular cells with the longest secretory signal sequence among eukaryotes, is up-regulated after vascular injury.

Authors:  K Kobuke; Y Furukawa; M Sugai; K Tanigaki; N Ohashi; A Matsumori; S Sasayama; T Honjo; K Tashiro
Journal:  J Biol Chem       Date:  2001-07-10       Impact factor: 5.157

Review 2.  Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells.

Authors:  Keiko Kawai-Kowase; Gary K Owens
Journal:  Am J Physiol Cell Physiol       Date:  2006-09-06       Impact factor: 4.249

3.  Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters.

Authors:  Tadashi Yoshida; Qiong Gan; Yueting Shang; Gary K Owens
Journal:  Am J Physiol Cell Physiol       Date:  2006-09-20       Impact factor: 4.249

4.  Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration.

Authors:  Jeffrey A Spencer; Shelby L Hacker; Elaine C Davis; Robert P Mecham; Russ H Knutsen; Dean Y Li; Robert D Gerard; James A Richardson; Eric N Olson; Hiromi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 5.  Role of platelet-derived growth factors in physiology and medicine.

Authors:  Johanna Andrae; Radiosa Gallini; Christer Betsholtz
Journal:  Genes Dev       Date:  2008-05-15       Impact factor: 11.361

6.  Modulation of smooth muscle proliferation in rat carotid artery by platelet-derived mediators and fibroblast growth factor-2.

Authors:  C D Lewis; N E Olson; E W Raines; M A Reidy; C L Jackson
Journal:  Platelets       Date:  2001-09       Impact factor: 3.862

Review 7.  The Cbl family proteins: ring leaders in regulation of cell signaling.

Authors:  Gayathri Swaminathan; Alexander Y Tsygankov
Journal:  J Cell Physiol       Date:  2006-10       Impact factor: 6.384

8.  Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo.

Authors:  Katsumi Koshikawa; Hirotaka Osada; Ken-Ichi Kozaki; Hiroyuki Konishi; Akira Masuda; Yoshio Tatematsu; Tetsuya Mitsudomi; Akimasa Nakao; Takashi Takahashi
Journal:  Oncogene       Date:  2002-04-25       Impact factor: 9.867

9.  ESDN is a marker of vascular remodeling and regulator of cell proliferation in graft arteriosclerosis.

Authors:  M M Sadeghi; L Esmailzadeh; J Zhang; X Guo; A Asadi; S Krassilnikova; H R Fassaei; G Luo; R S M Al-Lamki; T Takahashi; G Tellides; J R Bender; E R Rodriguez
Journal:  Am J Transplant       Date:  2007-09       Impact factor: 8.086

10.  Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.

Authors:  Yumei Zhan; Shokei Kim; Yasukatsu Izumi; Yasuhiro Izumiya; Takafumi Nakao; Hitoshi Miyazaki; Hiroshi Iwao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-13       Impact factor: 8.311

View more
  13 in total

1.  EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis.

Authors:  Haizhong Feng; Giselle Y Lopez; Chung Kwon Kim; Angel Alvarez; Christopher G Duncan; Ryo Nishikawa; Motoo Nagane; An-Jey A Su; Philip E Auron; Matthew L Hedberg; Lin Wang; Jeffery J Raizer; John A Kessler; Andrew T Parsa; Wei-Qiang Gao; Sung-Hak Kim; Mutsuko Minata; Ichiro Nakano; Jennifer R Grandis; Roger E McLendon; Darell D Bigner; Hui-Kuan Lin; Frank B Furnari; Webster K Cavenee; Bo Hu; Hai Yan; Shi-Yuan Cheng
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

2.  Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis.

Authors:  Lei Nie; Xiaojia Guo; Leila Esmailzadeh; Jiasheng Zhang; Abolfazl Asadi; Mark Collinge; Xuan Li; Jun-Dae Kim; Melissa Woolls; Suk-Won Jin; Alexandre Dubrac; Anne Eichmann; Michael Simons; Jeffrey R Bender; Mehran M Sadeghi
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

Review 3.  Novel tyrosine kinase signaling pathways: implications in vascular remodeling.

Authors:  Sri N Batchu; Vyacheslav A Korshunov
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-03       Impact factor: 2.894

4.  Potentiation of platelet-derived growth factor receptor-β signaling mediated by integrin-associated MFG-E8.

Authors:  Sei-ichiro Motegi; Susan Garfield; Xu Feng; Miklós Sárdy; Mark C Udey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

5.  Sparstolonin B suppresses rat vascular smooth muscle cell proliferation, migration, inflammatory response and lipid accumulation.

Authors:  Qing Liu; Jianping Li; Qiaoli Liang; Dawei Wang; Yi Luo; Fang Yu; Joseph S Janicki; Daping Fan
Journal:  Vascul Pharmacol       Date:  2015-04-11       Impact factor: 5.773

6.  PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress.

Authors:  Joshua K Salabei; Timothy D Cummins; Mahavir Singh; Steven P Jones; Aruni Bhatnagar; Bradford G Hill
Journal:  Biochem J       Date:  2013-05-01       Impact factor: 3.857

7.  Potential association of DCBLD2 polymorphisms with fall rates of FEV(1) by aspirin provocation in Korean asthmatics.

Authors:  Tae-Joon Park; Jeong-Hyun Kim; Byung-Lae Park; Hyun Sub Cheong; Joon Seol Bae; Charisse F Pasaje; Jong-Sook Park; Soo-Taek Uh; Mi-Kyeong Kim; Inseon S Choi; Choon-Sik Park; Hyoung Doo Shin
Journal:  J Korean Med Sci       Date:  2012-03-21       Impact factor: 2.153

8.  The neuropilin-like protein ESDN regulates insulin signaling and sensitivity.

Authors:  Xuan Li; Jae-Joon Jung; Lei Nie; Mahmoud Razavian; Jiasheng Zhang; Varman Samuel; Mehran M Sadeghi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-02-26       Impact factor: 5.125

9.  ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3.

Authors:  Roberto Coppo; Francesca Orso; Federico Virga; Alberto Dalmasso; Desirée Baruffaldi; Lei Nie; Fabiana Clapero; Daniela Dettori; Lorena Quirico; Elena Grassi; Paola Defilippi; Paolo Provero; Donatella Valdembri; Guido Serini; Mehran M Sadeghi; Massimiliano Mazzone; Daniela Taverna
Journal:  Cancer Lett       Date:  2021-04-13       Impact factor: 9.756

10.  Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARγ and TNFα signaling.

Authors:  Stefano Maria Pagnotta; Carmelo Laudanna; Massimo Pancione; Lina Sabatino; Carolina Votino; Andrea Remo; Luigi Cerulo; Pietro Zoppoli; Erminia Manfrin; Vittorio Colantuoni; Michele Ceccarelli
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.